Adrien Flahault
Adrien Flahault, MD, PhD is an expert in Cardiology at Centre Hospitalier Universitaire de Nancy (France). Adrien Flahault has authored 82 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 11 of them ongoing. SLR score: 541 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Nephrology - Transplantation - Urology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2006 - 2026
Number : 82
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Comparable outcomes with anti-thymocyte globulins versus basiliximab in kidney transplantation from controlled circulatory death donors. PMID 42305652 — thymocytes, kidney, delayed graft function, transplants, kidney transplantation, basiliximab, globulins, transplantation | Transpl Int | 2026 | 0 |
| Clinical study: Cardiovascular outcomes after a 14-week exercise intervention in young adults born preterm. PMID 42236922 — exercise, life style, blood, parturition, blood pressure, premature birth, pediatrics | Pediatr Res | 2026 | 0 |
| Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial. PMID 42240165 — kidney diseases, hemorrhage, stroke, rivaroxaban, kidney, arteries, peripheral arterial disease | JAMA Top journal | 2026 | 0 |
| Kidney biopsy during pregnancy: indications, complications, results and therapeutic impact. PMID 42148809 — pregnancy, safety, parturition, gestational age, lupus nephritis, kidney, biopsy, nephrotic syndrome, diagnosis, therapeutics, glomerulonephritis | Nephrol Dial Transplant | 2026 | 0 |
| Copeptin is a reliable biomarker of vasopressin and is associated with urine osmolality in patients on peritoneal dialysis. PMID 41774669 — kidney diseases, peritoneal dialysis, biomarkers, nephrology, kidney transplantation | J Nephrol | 2026 | 0 |
Clinical Studies 15
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
11 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin alone and how safe it is in adults with chronic kidney disease (CKD) and high blood pressure 2023-506457-38-00 — kidney diseases, hypertension, safety, blood, blood pressure, double-blind method, kidney | Phase 3 | Active not recruiting | 2024 |
| A study to find out if BI 764198 helps adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS) 2025-522191-86-00 — genes, kidney, adolescent, glomerulosclerosis, focal segmental, therapeutics, trpc6 cation channel | Phase 3 | Not yet recruiting | 2026 |
| A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adults with chronic kidney disease (CKD) and high blood pressure 2023-506460-14-00 — kidney diseases, hypertension, mortality, safety, blood, blood pressure, kidney | Phase 3 | Recruiting | 2025 |
| A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and or Chronic Kidney Disease (ATTAIN Outcomes) 2025-523123-22-00 — kidney diseases, incidence, cardiovascular diseases, kidney, atherosclerosis | Phase 3 | Recruiting | 2026 |
| Avacopan Added to Standard of care Therapy in ANCA associated Vasculitis With Severe Kidney Involvement NCT07373262 — kidney diseases, glucocorticoids, vasculitis, mortality, neutrophils, kidney, anti-neutrophil cytoplasmic antibody-associated vasculitis, antibodies, antineutrophil cytoplasmic, therapeutics | Phase 3 | Not yet recruiting | 2026 |
LeadR Networks
Main global connection map